Physician profile
Edward Joy
NPI 1205049061
$4,209.47
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,642 · 2020: $242 · 2021: $257 · 2022: $1,283 · 2024: $635 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $471 · Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $471.23 |
| Food and Beverage | $314.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $1,775.61 | 2019-2024 | Djo Surgical |
| Medwest Associates | $1,666.00 | 2019-2022 | |
| Arthrosurface Incorporated | $161.41 | 2020 | |
| Medacta USA, INC. | $147.08 | 2021 | |
| Stryker Corporation | $88.08 | 2022-2024 | Ortholoc 3di |
| Ferring Pharmaceuticals INC. | $81.96 | 2025 | Euflexxa |
| Wright Medical Technology, INC. | $80.26 | 2020 | |
| Depuy Synthes Sales INC. | $63.22 | 2022-2025 | Dynacord, Fms, Gryphon Orthocord |
| Abbott Laboratories | $53.57 | 2021-2025 | Proclaim |
| Arthrex, INC. | $30.00 | 2019 | |
| Si-Bone, INC. | $25.45 | 2019 | |
| Molnlycke Health Care US, LLC | $20.37 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Boston Scientific Corporation | $16.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Joy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.